The COVID-19 and the Rise in Cancer Mortality
Randall A. Oyer, MD, discusses rising cancer mortality during the coronavirus disease 2019 (COVID-19) pandemic and what that means for cancer care.
Pharmacy Times® interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers and medical director at Ann B. Barshinger Cancer Institute, Penn Medicine in Lancaster, Pennsylvania about rising cancer mortality during the coronavirus disease 2019 (COVID-19) pandemic and what that means for cancer care.
This is a partial transcript. View the video for the full discussion.
Randall A. Oyer, MD: Well, I’m a medical oncologist and I have been practicing for more than 30 years, and each year we’ve seen the cancer mortality go down, almost 1% a year since I’ve finished my training. And that’s something that’s obviously very important to us working in the cancer field, and we’ve been interrupted by COVID.
